Can B Corp (CANB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Can B Corp (CANB) has a cash flow conversion efficiency ratio of -0.001x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.10K) by net assets ($-9.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Can B Corp (CANB) net asset quality to measure how much of total assets are equity-financed.
Can B Corp - Cash Flow Conversion Efficiency Trend (2010–2023)
This chart illustrates how Can B Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Can B Corp to evaluate the quality of earnings relative to operating cash generation.
Can B Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Can B Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Healthcare Triangle Inc
NASDAQ:HCTI
|
-0.132x |
|
Ceylon Graphite Corp
V:CYL
|
1.418x |
|
Crown LNG Holdings Limited Warrants
NASDAQ:CGBSW
|
-0.192x |
|
Martela Oyj A
HE:MARAS
|
0.082x |
|
ORIGEN RESOURCES INC. NEW
F:4VXA
|
N/A |
|
Falcon Oil & Gas Ltd.
LSE:FOG
|
-0.027x |
|
Divio Technologies AB Series B
ST:DIVIO-B
|
0.255x |
|
Webac Holding AG
F:RKB
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Can B Corp (2010–2023)
The table below shows the annual cash flow conversion efficiency of Can B Corp from 2010 to 2023. For the full company profile with market capitalisation and key ratios, see CANB market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-1.00 Million | $-1.30 Million | 1.302x | +188.98% |
| 2022-12-31 | $2.70 Million | $-3.95 Million | -1.463x | -12.28% |
| 2021-12-31 | $5.62 Million | $-7.32 Million | -1.303x | -117.90% |
| 2020-12-31 | $3.26 Million | $-1.95 Million | -0.598x | -57.75% |
| 2019-12-31 | $6.37 Million | $-2.41 Million | -0.379x | -75.52% |
| 2018-12-31 | $3.49 Million | $-753.57K | -0.216x | -230.51% |
| 2017-12-31 | $-1.73 Million | $-286.29K | 0.165x | -40.21% |
| 2016-12-31 | $-514.59K | $-142.43K | 0.277x | +107.70% |
| 2015-12-31 | $99.99K | $-359.62K | -3.597x | -3813.38% |
| 2014-12-31 | $98.82K | $-9.08K | -0.092x | +98.50% |
| 2013-12-31 | $61.42K | $-375.97K | -6.121x | +61.68% |
| 2012-12-31 | $34.72K | $-554.69K | -15.975x | -4647.76% |
| 2011-12-31 | $1.18 Million | $-396.78K | -0.336x | -139.19% |
| 2010-12-31 | $-174.70K | $-149.99K | 0.859x | -- |
About Can B Corp
Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website… Read more